151 related articles for article (PubMed ID: 32932980)
1. Novel Dietary Proteins Selectively Affect Intestinal Health In Vitro after
Jochems PGM; Garssen J; Rietveld PCS; Govers C; Tomassen MMM; Wichers HJ; van Bergenhenegouwen J; Masereeuw R
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32932980
[TBL] [Abstract][Full Text] [Related]
2. The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.
Hansen A; Alston L; Tulk SE; Schenck LP; Grassie ME; Alhassan BF; Veermalla AT; Al-Bashir S; Gendron FP; Altier C; MacDonald JA; Beck PL; Hirota SA
PLoS One; 2013; 8(11):e81491. PubMed ID: 24278446
[TBL] [Abstract][Full Text] [Related]
3. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
4. Extra-Intestinal Effects of
Tonon F; Di Bella S; Grassi G; Luzzati R; Ascenzi P; di Masi A; Zennaro C
Cells; 2020 Dec; 9(12):. PubMed ID: 33271969
[No Abstract] [Full Text] [Related]
5. A new role for heat shock factor 27 in the pathophysiology of
Yanda MK; Guggino WB; Cebotaru L
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G120-G129. PubMed ID: 31709831
[No Abstract] [Full Text] [Related]
6. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
7. Differential effects of Clostridium difficile toxins on ion secretion and cell integrity in human intestinal cells.
Buccigrossi V; Lo Vecchio A; Marano A; Guarino A
Pediatr Res; 2019 Jun; 85(7):1048-1054. PubMed ID: 30851723
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
[TBL] [Abstract][Full Text] [Related]
9. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
10.
Dong L; Tomassen MM; Ariëns RMC; Oosterink E; Wichers HJ; Veldkamp T; Mes JJ; Govers C
Food Funct; 2021 Oct; 12(19):9248-9260. PubMed ID: 34606540
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.
Ng J; Hirota SA; Gross O; Li Y; Ulke-Lemee A; Potentier MS; Schenck LP; Vilaysane A; Seamone ME; Feng H; Armstrong GD; Tschopp J; Macdonald JA; Muruve DA; Beck PL
Gastroenterology; 2010 Aug; 139(2):542-52, 552.e1-3. PubMed ID: 20398664
[TBL] [Abstract][Full Text] [Related]
12. Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
Qiu H; Cassan R; Johnstone D; Han X; Joyee AG; McQuoid M; Masi A; Merluza J; Hrehorak B; Reid R; Kennedy K; Tighe B; Rak C; Leonhardt M; Dupas B; Saward L; Berry JD; Nykiforuk CL
PLoS One; 2016; 11(6):e0157970. PubMed ID: 27336843
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Alginate and Chitosan Oligosaccharides against
Mavrogeni ME; Asadpoor M; Judernatz JH; van Ark I; Wösten MMSM; Strijbis K; Pieters RJ; Folkerts G; Braber S
Toxins (Basel); 2023 Sep; 15(10):. PubMed ID: 37888617
[No Abstract] [Full Text] [Related]
14. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
16. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.
Leslie JL; Huang S; Opp JS; Nagy MS; Kobayashi M; Young VB; Spence JR
Infect Immun; 2015 Jan; 83(1):138-45. PubMed ID: 25312952
[TBL] [Abstract][Full Text] [Related]
17. Lathyrus sativus diamine oxidase reduces Clostridium difficile toxin A-induced toxicity in Caco-2 cells by rescuing RhoA-GTPase and inhibiting pp38-MAPK/NF-κB/HIF-1α activation.
Pietrangeli P; Corpetti C; Seguella L; Del Re A; Pesce M; Vincenzi M; Lori C; Annunziata G; Mateescu MA; Sarnelli G; Esposito G; Marcocci L
Phytother Res; 2021 Jan; 35(1):415-423. PubMed ID: 32914548
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward
Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A
Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980
[TBL] [Abstract][Full Text] [Related]
19. Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.
Sutton PA; Li S; Webb J; Solomon K; Brazier J; Mahida YR
Clin Exp Immunol; 2008 Sep; 153(3):439-47. PubMed ID: 18505424
[TBL] [Abstract][Full Text] [Related]
20. Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B.
Simeon R; Jiang M; Chamoun-Emanuelli AM; Yu H; Zhang Y; Meng R; Peng Z; Jakana J; Zhang J; Feng H; Chen Z
PLoS Biol; 2019 Jun; 17(6):e3000311. PubMed ID: 31233493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]